Researchers: Nhat-Tu Le
Endothelial cell (EC) senescence is increasingly recognized as a significant contributor to the development of vascular dysfunction and age-related disorders and diseases, including cancer and cardiovascular diseases (CVD). The regulation of cellular senescence is known to be influenced by cellular metabolism. While extensive research has been conducted on the metabolic regulation of senescence in other cells such as cancer cells and fibroblasts, our understanding of the metabolic regulation of EC senescence remains limited. The specific metabolic changes that drive EC senescence are yet to be fully elucidated. The objective of this review is to provide an overview of the intricate interplay between cellular metabolism and senescence, with a particular emphasis on recent advancements in understanding the metabolic changes preceding cellular senescence. I will summarize the current knowledge on the metabolic regulation of EC senescence, aiming to offer insights into the underlying mechanisms and future research directions.
References
- The hallmarks of aging.
- Is Caloric Restriction Associated with Better Healthy Aging Outcomes? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.
- DNA damage and repair in age-related inflammation.
- Senolytic drugs: from discovery to translation.
- The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation.
- NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease.
- Age-Dependent Decline of NAD+-Universal Truth or Confounded Consensus?
- NAD+ in Brain Aging and Neurodegenerative Disorders.
- Senescence and cancer - role and therapeutic opportunities.
- Cellular senescence: the good, the bad and the unknown.
- Mechanisms of Vascular Aging.
- Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.
- Vascular Endothelial Senescence: Pathobiological Insights, Emerging Long Noncoding RNA Targets, Challenges and Therapeutic Opportunities.
- Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics.